Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects

SIMPLE SUMMARY: Pancreatic neuroendocrine tumors (PanNETs) are often diagnosed when advanced or metastatic, and at this stage curative surgery in no longer an option. Given that available treatments for advanced disease have shown limited efficacy, novel therapies are urgently needed. In this scenar...

Descripción completa

Detalles Bibliográficos
Autores principales: Gulde, Sebastian, Foscarini, Alessia, April-Monn, Simon L., Genio, Edoardo, Marangelo, Alessandro, Satam, Swapna, Helbling, Daniel, Falconi, Massimo, Toledo, Rodrigo A., Schrader, Jörg, Perren, Aurel, Marinoni, Ilaria, Pellegata, Natalia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688197/
https://www.ncbi.nlm.nih.gov/pubmed/36428573
http://dx.doi.org/10.3390/cancers14225481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688197/
https://www.ncbi.nlm.nih.gov/pubmed/36428573
http://dx.doi.org/10.3390/cancers14225481

Ejemplares similares